CBC on Tour: Breath Biopsy–a New Paradigm for Early Detection of Cancer & Other Diseases
It is a sobering statistic that one in two of us will get cancer in our lifetimes and cancer is the second leading cause of death globally. Early detection is our greatest opportunity, with estimates that if detected early, approximately half of lung cancer patients and three quarters percent of colon cancer patients can be cured with treatments that exist today compared with only 5% and 10% respectively today.
Breath Biopsy has the potential to directly transform this dynamic by detecting volatile organic compounds produced or modified by metabolic processes within the body – changes in which can be characteristic of specific disease.
Billy Boyle is an engineering graduate from Cambridge University. He is one of the original co-founders of Owlstone Inc, spun out of Cambridge in 2004, which has raised $28 million in investment and won >$25 million in defence contracts. He initially worked with silicon foundries in the design and fabrication of the core microchip technology and is co-inventor on 19 patents. He then assumed a commercial role with P&L responsibility for the Scientific Instruments and Industrial business units; responsible for sales of FAIMS products and contracts with >150 clients globally, including Agilent, Thermo, Roche Diagnostics, Samsung, GSK, 4D Pharma, Mayo Clinic and the NHS.
Billy started to focus on the medical applications of FAIMS technology after his wife, Kate, was diagnosed and later died of colon cancer as a result of a late diagnosis. He worked closely with clinical partners who integrated FAIMS technology across a broad spectrum of clinical trials in cancer, inflammatory disease & infectious disease.
This event is part of the new series of the ‘CBC on Virtual Tour’ – the chance to learn more about the Cambridge Biomedical Campus where over 20,000 people at the forefront of the changing face of healthcare are working.
This event will be recorded and a link will be sent to all participants afterwards. It will also be posted on the CUHP website and the CUHP YouTube channel.